Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,923 | -64,965 | -243,407 | -51,536 | -31,718 |
| Depreciation Amortization | 2,210 | 1,041 | 395 | 83 | 9 |
| Income taxes - deferred | -1,619 | 0 | N/A | 0 | N/A |
| Accounts receivable | -11 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,723 | -400 | 1,619 | 4,455 | -2,479 |
| Other Working Capital | 48,006 | 36,860 | 79,159 | -1,763 | -3,962 |
| Other Operating Activity | 5,456 | 5,815 | 79,689 | 9,346 | 14,785 |
| Operating Cash Flow | $-70,158 | $-21,649 | $-82,545 | $-39,415 | $-23,365 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -222,178 | -181,313 | -121,827 | -3,455 | -3,455 |
| PPE Investments | -9,154 | -2,342 | -2,958 | -1,636 | -715 |
| Net Acquisitions | -77,666 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 64,115 | 15,201 | N/A | 0 | 0 |
| Investing Cash Flow | $-244,883 | $-168,454 | $-124,785 | $-5,091 | $-4,170 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -82 | -24 | N/A | N/A | N/A |
| Common Stock Issued | -1,315 | -1,683 | 281,383 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 245,949 | 246,374 | 62,614 |
| Financing Cash Flow | $-1,397 | $-1,707 | $527,332 | $246,374 | $62,614 |
| Exchange Rate Effect | -12 | 0 | N/A | 0 | N/A |
| Beginning Cash Position | 355,968 | 355,968 | 35,966 | 35,966 | 35,966 |
| End Cash Position | 39,518 | 164,158 | 355,968 | 237,834 | 71,045 |
| Net Cash Flow | $-316,450 | $-191,810 | $320,002 | $201,868 | $35,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,158 | -21,649 | -82,545 | -39,415 | -23,365 |
| Capital Expenditure | -9,154 | -2,342 | -2,958 | -1,636 | -715 |
| Free Cash Flow | -79,312 | -23,991 | -85,503 | -41,051 | -24,080 |